(Q54333542)

English

The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience.

scientific article published on 16 December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience. (English)

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

0 references

sulfamethoxazole/trimethoprim

1 reference

based on heuristic

inferred from title

7

object named as

Irit Avivi

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

author name string

Emilia Hardak

1

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

Ilana Oren

2

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

Eldad J Dann

3

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

Mordechai Yigla

4

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

Tal Faibish

5

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

Jacob M Rowe

6

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

publication date

16 December 2011

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

Acta Haematologica

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

127

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

110-114

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

2

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres.

1 reference

https://api.crossref.org/works/10.1159%2F000334113

21 January 2018

High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone

1 reference

https://api.crossref.org/works/10.1159%2F000334113

21 January 2018

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1159%2F000334113

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1159%2F000334113

21 January 2018

Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen.

1 reference

https://api.crossref.org/works/10.1159%2F000334113

21 January 2018

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

1 reference

https://api.crossref.org/works/10.1159%2F000334113

21 January 2018

Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1159%2F000334113

21 January 2018

Does rituximab increase the incidence of infectious complications? A narrative review

1 reference

https://api.crossref.org/works/10.1159%2F000334113

21 January 2018

A resurgence of Pneumocystis in aggressive lymphoma treated with R-CHOP-14: the price of a dose-dense regimen?

1 reference

https://api.crossref.org/works/10.1159%2F000334113

21 January 2018

Current understanding of Pneumocystis immunology

1 reference

https://api.crossref.org/works/10.1159%2F000334113

21 January 2018

Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients

1 reference

https://api.crossref.org/works/10.1159%2F000334113

21 January 2018

Identifiers

10.1159/000334113

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22178955

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54333542&oldid=1561878590"